Global epidemiology of cirrhosis - aetiology, trends and predictions

被引:298
作者
Huang, Daniel Q. [1 ,2 ,3 ]
Terrault, Norah A. [4 ]
Tacke, Frank [5 ,6 ]
Gluud, Lise Lotte [7 ,8 ]
Arrese, Marco [9 ,10 ]
Bugianesi, Elisabetta [11 ]
Loomba, Rohit [1 ,12 ]
机构
[1] Univ Calif San Diego, NAFLD Res Ctr, Div Gastroenterol, San Diego, CA 92093 USA
[2] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Med, Singapore, Singapore
[3] Natl Univ Hlth Syst, Dept Med, Div Gastroenterol & Hepatol, Singapore, Singapore
[4] Univ Southern Calif, Div Gastrointestinal & Liver Dis, Los Angeles, CA USA
[5] Charite Univ Med Berlin, Dept Hepatol & Gastroenterol, Campus Virchow Klinikum, Berlin, Germany
[6] Charite Univ Med Berlin, Campus Charite Mitte, Berlin, Germany
[7] Copenhagen Univ Hosp, Gastro Unit, Hvidovre, Denmark
[8] Univ Copenhagen, Fac Hlth Sci, Dept Clin Med, Copenhagen, Denmark
[9] Pontificia Univ Catolica Chile, Escuela Med, Dept Gastroenterol, Santiago, Chile
[10] Pontificia Univ Catolica Chile, Fac Ciencias Biol, Ctr Envejecimiento & Regenerac CARE, Santiago, Chile
[11] Univ Turin, Dept Med Sci, Div Gastroenterol & Hepatol, Turin, Italy
[12] Univ Calif San Diego, Dept Family Med & Publ Hlth, Div Epidemiol, San Diego, CA 92093 USA
关键词
FATTY LIVER-DISEASE; HEPATITIS-B; NONALCOHOLIC STEATOHEPATITIS; HEPATOCELLULAR-CARCINOMA; DECOMPENSATED CIRRHOSIS; NATURAL-HISTORY; BURDEN; PREVALENCE; MANAGEMENT; ALCOHOL;
D O I
10.1038/s41575-023-00759-2
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Cirrhosis is an important cause of morbidity and mortality in people with chronic liver disease worldwide. In 2019, cirrhosis was associated with 2.4% of global deaths. Owing to the rising prevalence of obesity and increased alcohol consumption on the one hand, and improvements in the management of hepatitis B virus and hepatitis C virus infections on the other, the epidemiology and burden of cirrhosis are changing. In this Review, we highlight global trends in the epidemiology of cirrhosis, discuss the contributions of various aetiologies of liver disease, examine projections for the burden of cirrhosis, and suggest future directions to tackle this condition. Although viral hepatitis remains the leading cause of cirrhosis worldwide, the prevalence of non-alcoholic fatty liver disease (NAFLD) and alcohol-associated cirrhosis are rising in several regions of the world. The global number of deaths from cirrhosis increased between 2012 and 2017, but age-standardized death rates (ASDRs) declined. However, the ASDR for NAFLD-associated cirrhosis increased over this period, whereas ASDRs for other aetiologies of cirrhosis declined. The number of deaths from cirrhosis is projected to increase in the next decade. For these reasons, greater efforts are required to facilitate primary prevention, early detection and treatment of liver disease, and to improve access to care. In this Review, Huang et al. highlight global trends in the epidemiology of cirrhosis, including contributions of various aetiologies of liver disease, and consider what needs to be done to address projected increases in the burden of cirrhosis.
引用
收藏
页码:388 / 398
页数:11
相关论文
共 132 条
  • [11] Burden of liver diseases in the world
    Asrani, Sumeet K.
    Devarbhavi, Harshad
    Eaton, John
    Kamath, Patrick S.
    [J]. JOURNAL OF HEPATOLOGY, 2019, 70 (01) : 151 - 171
  • [12] Validity of administrative codes associated with cirrhosis in Sweden
    Bengtsson, Bonnie
    Askling, Johan
    Ludvigsson, Jonas F.
    Hagstrom, Hannes
    [J]. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2020, 55 (10) : 1205 - 1210
  • [13] Trends in Liver Transplantation for Acute Alcohol-Associated Hepatitis During the COVID-19 Pandemic in the US
    Bittermann, Therese
    Mahmud, Nadim
    Abt, Peter
    [J]. JAMA NETWORK OPEN, 2021, 4 (07)
  • [14] Global change in hepatitis C virus prevalence and cascade of care between 2015 and 2020: a modelling study
    Blach, Sarah
    Terrault, Norah A.
    Tacke, Frank
    Gamkrelidze, Ivane
    Craxi, Antonio
    Tanaka, Junko
    Waked, Imam
    Dore, Gregory J.
    Abbas, Zaigham
    Abdallah, Ayat R.
    Abdulla, Maheeba
    Aghemo, Alessio
    Aho, Inka
    Akarca, Ulus S.
    Alalwan, Abduljaleel M.
    Blome, Marianne Alanko
    Al-Busafi, Said A.
    Aleman, Soo
    Alghamdi, Abdullah S.
    Al-Hamoudi, Waleed K.
    Aljumah, Abdulrahman A.
    Al-Naamani, Khalid
    Al Serkal, Yousif M.
    Altraif, Ibrahim H.
    Anand, Anil C.
    Anderson, Motswedi
    Andersson, Monique, I
    Athanasakis, Kostas
    Baatarkhuu, Oidov
    Bakieva, Shokhista R.
    Ben-Ari, Ziv
    Bessone, Fernando
    Biondi, Mia J.
    Bizri, Abdul Rahman N.
    Mello, Carlos E. Brandaoo
    Brigida, Krestina
    Brown, Kimberly A.
    Brown, Robert S., Jr.
    Bruggmann, Philip
    Brunetto, Maurizia R.
    Busschots, Dana
    Buti, Maria
    Butsashvili, Maia
    Cabezas, Joaquin
    Chae, Chungman
    Ivanova, Viktorija Chaloska
    Chan, Henry Lik Yuen
    Cheinquer, Hugo
    Cheng, Kent Jason
    Cheon, Myeong Eun
    [J]. LANCET GASTROENTEROLOGY & HEPATOLOGY, 2022, 7 (05): : 396 - 415
  • [15] Impact of COVID-19 on global HCV elimination efforts
    Blach, Sarah
    Kondili, Loreta A.
    Aghemo, Alessio
    Cai, Zongzhen
    Dugan, Ellen
    Estes, Chris
    Gamkrelidze, Ivane
    Ma, Siya
    Pawlotsky, Jean-Michel
    Razavi-Shearer, Devin
    Razavi, Homie
    Waked, Imam
    Zeuzem, Stefan
    Craxi, Antonio
    [J]. JOURNAL OF HEPATOLOGY, 2021, 74 (01) : 31 - 36
  • [16] EASL Clinical Practice Guidelines: Liver transplantation
    Burra, Patrizia
    Burroughs, Andrew
    Graziadei, Ivo
    Pirenne, Jacques
    Valdecasas, Juan Carlos
    Muiesan, Paolo
    Samuel, Didier
    Forns, Xavier
    Burroughs, Andrew
    [J]. JOURNAL OF HEPATOLOGY, 2016, 64 (02) : 433 - 485
  • [17] Long-Term Entecavir Therapy Results in the Reversal of Fibrosis/Cirrhosis and Continued Histological Improvement in Patients with Chronic Hepatitis B
    Chang, Ting-Tsung
    Liaw, Yun-Fan
    Wu, Shun-Sheng
    Schiff, Eugene
    Han, Kwang-Hyub
    Lai, Ching-Lung
    Safadi, Rifaat
    Lee, Samuel S.
    Halota, Waldemar
    Goodman, Zachary
    Chi, Yun-Chan
    Zhang, Hui
    Hindes, Robert
    Iloeje, Uchenna
    Beebe, Suzanne
    Kreter, Bruce
    [J]. HEPATOLOGY, 2010, 52 (03) : 886 - 893
  • [18] Charatcharoenwitthaya Phunchai, 2020, Clin Liver Dis (Hoboken), V16, P231, DOI 10.1002/cld.920
  • [19] Anti-viral therapy is associated with improved survival but is underutilised in patients with hepatitis B virus-related hepatocellular carcinoma: real-world east and west experience
    Chen, V. L.
    Yeh, M. -L.
    Le, A. K.
    Jun, M.
    Saeed, W. K.
    Yang, J. D.
    Huang, C. -F.
    Lee, H. Y.
    Tsai, P. -C.
    Lee, M. -H.
    Giama, N.
    Kim, N. G.
    Nguyen, P. P.
    Dang, H.
    Ali, H. A.
    Zhang, N.
    Huang, J. -F.
    Dai, C. -Y.
    Chuang, W. -L.
    Roberts, L. R.
    Jun, D. W.
    Lim, Y. -S.
    Yu, M. -L.
    Nguyen, M. H.
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2018, 48 (01) : 44 - 54
  • [20] Progress towards elimination goals for viral hepatitis
    Cox, Andrea L.
    El-Sayed, Manal H.
    Kao, Jia-Horng
    Lazarus, Jeffrey V.
    Lemoine, Maud
    Lok, Anna S.
    Zoulim, Fabien
    [J]. NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY, 2020, 17 (09) : 533 - 542